Legal News

MOVERS: Cooley Godward's Sato joins Acucela's Board of Directors

By Richard Binder

Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today the appointment of Glen Y. Sato, a partner in the Life Sciences and Corporate practice groups of the law firm Cooley Godward Kronish LLP, to its Board of Directors.

Mr. Sato rejoined the Palo Alto, Calif. offices of Cooley Godward Kronish in 2006 and brings to Acucela significant experience with corporate transactions, intellectual property licensing and licensing strategy, general corporate counseling and corporate partnering involving leading pharmaceutical and biotechnology companies. Prior to joining the firm, Mr. Sato was Senior Vice President and Chief Financial Officer of Protein Design Labs, Inc. (PDL). Throughout his career, he has served in various legal, financial, operational and strategic planning positions at PDL, Exelixis and NeXT Computer, Inc. He began his career as an attorney at Cooley Godward Kronish in Palo Alto and Jones, Day in Washington, D.C. Mr. Sato received his J.D. and M.B.A. from the University of California, Los Angeles. He received his B.S. degree from Wesleyan University.

Full story here.

Full post as published by Legal Pad | LA on September 09, 2009 (boomark / email).